Prognostic stratification of coronary microvascular dysfunction in STEMI patients with or without diabetes mellitus
Acta Diabetologica · 2025
DOI: 10.1007/s00592-025-02600-5 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Diabetologica, 2025. Verfasst von Yiyue Zheng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou, 310009, China. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Microcirculation, Diabetes Mellitus. Die Arbeit nennt 57 Literaturangaben. Gefördert von: the Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
AIM: This study aims to investigate the interplay between post-percutaneous coronary intervention (PCI) microvascular dysfunction and diabetes mellitus (DM) in patients with ST-segment elevation myocardial infarction (STEMI) and their combined impact on prognosis. METHODS: This retrospective study included 1,629 STEMI patients who successfully underwent PCI across three centers. Angio-IMR (angiography-derived index of microcirculatory resistance) was retrospectively measured. The primary endpoint was 2-year major adverse cardiac events (MACE), defined as a composite of cardiac death, readmission for heart failure, myocardial re-infarction, and target vessel revascularization. RESULT: Among the 1,629 patients, 448(27.5%) had diabetes. Post-PCI angio-IMR value did not differ significantly between DM and non-DM group (33.04 [interquartile range (IQR) 22.20-43.20] vs. 32.02[IQR 22.57-41.60]; P = 0.420). Patients with post-PCI angio-IMR > 40 had significantly higher rates of MACE, irrespective of diabetes status (DM group: 23.1% vs. 6.7%; P 40 had the highest hazard ratio (HR) for MACE after adjustment (HR 5.076; 95% confidence interval, 3.157-8.161; P 40 had the highest 2-year adverse event rates, underscoring the need for targeted risk assessment and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou, 310009, China.
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
- Cardiovascular Key Laboratory Zhejiang Province, Hangzhou, China.
- Transvascular Implant Instrument Research Institute, The Second Affiliated Hospital Zhejiang University School of Medicine, Binjiang District, 310053, Hangzhou, China.
- Xinjiang Medical University Xinjiang Uygur Autonomous Region People's Hospital, Binjiang District, 830063, Urumqi, Xinjiang, China.
- Taizhou Hospital, Zhejiang University, School of Medicine, Taizhou, China.
Förderung
- the Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
- Key Research and Development Program of Zhejiang Province
Zitieren
APA
Zheng, Y., Shadeerding, A., Zhang, Y., Zhang, C., Yidilisi, A., Mei, T., Chen, Z., Chen, D., Fang, J., Ji, R., Zhang, X., Xiang, J., Niu, T., Pu, J., Wang, J., & Jiang, J. (2025). Prognostic stratification of coronary microvascular dysfunction in STEMI patients with or without diabetes mellitus. Acta Diabetologica. https://doi.org/10.1007/s00592-025-02600-5
Vancouver
Zheng Y, Shadeerding A, Zhang Y, Zhang C, Yidilisi A, Mei T, et al. Prognostic stratification of coronary microvascular dysfunction in STEMI patients with or without diabetes mellitus. Acta Diabetologica. 2025. doi:10.1007/s00592-025-02600-5
BibTeX
@article{Zheng2025,
author = {Zheng, Yiyue and Shadeerding, Abudushalamu and Zhang, Yuxuan and Zhang, Chenyun and Yidilisi, Abuduwufuer and Mei, Tingting and Chen, Zining and Chen, Delong and Fang, Jiacheng and Ji, Rui and Zhang, Xinyi and Xiang, Jianping and Niu, Tiesheng and Pu, Jun and Wang, Jian'an and Jiang, Jun},
title = {Prognostic stratification of coronary microvascular dysfunction in STEMI patients with or without diabetes mellitus},
journal = {Acta Diabetologica},
year = {2025},
doi = {10.1007/s00592-025-02600-5}
}
EUVIMED